EW:NYSE
Edwards Lifesciences Corp
85,21 USD
arrow_upward
+1,10%(+0,93) 1D
85,21 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 9-окт., 16:00:05 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
84,60 USD
High
85,34 USD
Low
83,22 USD
Mkt. cap
49,12 млд
Avg. vol.
3,43 млн
Volume
3,89 млн
P/E ratio
49,30
52-wk high
96,29 USD
52-wk low
72,30 USD
EPS
1,73 USD
Beta
0,87
Shares outstanding
576,40 млн
No. of employees
16 миң
Open
84,60 USD
High
85,34 USD
Low
83,22 USD
Mkt. cap
49,12 млд
Avg. vol.
3,43 млн
Volume
3,89 млн
P/E ratio
49,30
52-wk high
96,29 USD
52-wk low
72,30 USD
EPS
1,73 USD
Beta
0,87
Shares outstanding
576,40 млн
No. of employees
16 миң
News stories
From web sources and news partners
News Corp
·
1 күн мурун
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Investing.com Australia
·
3 күн мурун
UBS reiterates Edwards Lifesciences stock rating on endpoint expectations By Investing.com
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 миң
Founded1958
HeadquartersИрвайн, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Websiteedwards.com